Background: Neuropathic pain, which is very common after SCI, is confronted as a problem that affects the quality of life negatively and restricts the functional capacity of the patient
Objective: The aim of this study was to compare the efficacy of burst type transcutaneous electrical nerve stimulation (TENS) and conventional TENS therapy on pain, quality of life and disability in neuropathic pain following spinal cord injury (SCI).
Methods: The patients were randomly divided into two groups. Group 1 (n=20) received conventional-TENS therapy and group 2 (n=20) received burst-TENS for 15 sessions. Before and after the treatment, neuropathic pain was assessed with Douleur Neuropathique en 4 Questions (DN-4), pain severity was assessed with visual analogue scale (VAS), quality of life and functional status were evaluated with short form 36 (SF-36) and functional independence measure (FIM) scales.
Results: After the treatment VAS and DN-4 scores were significantly decreased in both groups (p<0.05). However, in group 2 (burst type TENS) reduction of the VAS scores was significantly higher than group 1 (conventional TENS) (p<0.05). After the treatment there were statistically significant improvements in physical function and body pain scores of SF-36 in both groups (p<0.05). There were significant improvements in FIM total scores in both groups (p<0.05) however the difference between the groups was not statistically significant (p>0.05).
Conclusions: TENS is a nonpharmacologic treatment modality which is useful in reducing neuropatic pain level, increasing quality of life and functional independence of the patient. In addition, we decided that burst-TENS is more effective than conventional-TENS for pain severity and neuropathic pain in patient with neuropathic pain syndrome due to SCI.
Tiago Almeida Costa*, Maria Adriely Cunha Lima, Larissa Aciole Maciel Teixeira, Mariana Soares Faria, Amanda Távora Oliveira, Halley Ferraro Oliveira
Online date : 2020-10-11 04:18:48
Dermatological Manifestations in Covid-19: A Systematic Review
Tiago Almeida Costa*, Maria Adriely Cunha Lima, Larissa Aciole Maciel Teixeira, Mariana Soares...
Methods: This article is a systematic review of literature about dermatological manifestations in SARS-CoV-2 infection. The database used for this research were PubMed Central® (PMC), Literatura Latino-americana e do Caribe em Ciências da Saúde (LILACS) e Scientific Electronic Library Online (SciELO). This search filters has been applied: articles published in 2020, descriptors only in the title or abstract and full text. After that, 34 articles were selected as base for this data research. Results: It was observed that urticaria is the most frequent manifestation, presented in 10 articles (71,4%) of 14 evaluated, followed by maculopapular eruptions, mentioned in 6 articles (42,8%), and itching, related in 5 articles (35,7%). In the case report analysis, specifically, it is possible to notice bigger prevalence of maculopapular lesions, mentioned in 8 case reports (40%), and urticarial, described in 7 case reports (35%). About the most affected parts by dermatological manifestations, stands out chest area, presented in 29 studies (85,3%), extremities, presented in 21 studies (61,8%), face, presented in 16 studies (47%) and oropharyngeal, presented in 10 studies (29,4%). Conclusion: concrete information about dermatological manifestations in COVID-19 is still unknown. Therefore, bigger studies are needed about these skin lesions to clarify pathophysiological knowledge of this virus with huge impact nowadays.